Larimar Therapeutics, Inc. (LRMR) stock
LRMRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.99−0.01 (-0.33%)
Close on Nov 17, 2026Market cap $310.61MP/E –Yield –
Larimar Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Larimar Therapeutics's market cap was $283.60M on Nov 11, 2026, against $302.99M a year earlier. Over the last 5 years it ranged from $31.70M to $535.28M, with a median of $221.54M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $283.60M | -13.0% |
| 2025 | Dec 31, 2025 | $326.10M | +32.1% |
| 2024 | Dec 31, 2024 | $246.93M | +23.6% |
| 2023 | Dec 29, 2023 | $199.77M | +11.8% |
| 2022 | Dec 30, 2022 | $178.70M | -6.5% |
| 2021 | Dec 31, 2021 | $191.10M | -41.9% |
| 2020 | Dec 31, 2020 | $328.78M | -34.0% |
| 2019 | Dec 31, 2019 | $497.79M | -77.3% |
| 2018 | Dec 31, 2018 | $2.19B | +43.7% |
| 2017 | Dec 29, 2017 | $1.52B | +46.1% |
| 2016 | Dec 30, 2016 | $1.04B | -49.3% |
| 2015 | Dec 31, 2015 | $2.06B | -75.5% |
| 2014 | Dec 31, 2014 | $8.40B | – |
See a number that looks wrong?